94 related articles for article (PubMed ID: 2154087)
1. Large cell carcinoma of the lung. Prognostic implications of histopathologic and immunohistochemical subtyping.
Ishida T; Kaneko S; Tateishi M; Oka T; Mitsudomi T; Sugimachi K; Hara N; Ohta M
Am J Clin Pathol; 1990 Feb; 93(2):176-82. PubMed ID: 2154087
[TBL] [Abstract][Full Text] [Related]
2. Clinical applications of the pathological properties of small cell carcinoma, large cell carcinoma, and adenoid cystic carcinoma of the lung.
Ishida T; Yano T; Sugimachi K
Semin Surg Oncol; 1990; 6(1):53-63. PubMed ID: 2154027
[TBL] [Abstract][Full Text] [Related]
3. [Central and peripheral type small cell carcinoma of the lung--histologic, immunohistochemical, and clinical analyses].
Nomori H; Ishihara T; Torikata C
Nihon Kyobu Geka Gakkai Zasshi; 1990 Jul; 38(7):1112-7. PubMed ID: 1698898
[TBL] [Abstract][Full Text] [Related]
4. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of serum tumor markers in patients with lung cancer.
Hatzakis KD; Froudarakis ME; Bouros D; Tzanakis N; Karkavitsas N; Siafakas NM
Respiration; 2002; 69(1):25-9. PubMed ID: 11844959
[TBL] [Abstract][Full Text] [Related]
7. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
[TBL] [Abstract][Full Text] [Related]
8. [Proliferation rate of small cell lung carcinoma. A cytomorphometric parameter with prognostic significance].
Kayser G; Gunzenhäuser I; Becker HD; Herth F; Kayser K
Pathologe; 2001 Sep; 22(5):326-32. PubMed ID: 11572113
[TBL] [Abstract][Full Text] [Related]
9. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
[TBL] [Abstract][Full Text] [Related]
10. Neural cell adhesion molecule and prognosis of surgically resected lung cancer.
Pujol JL; Simony J; Demoly P; Charpentier R; Laurent JC; Daurès JP; Lehmann M; Guyot V; Godard P; Michel FB
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1071-5. PubMed ID: 8214927
[TBL] [Abstract][Full Text] [Related]
11. Co-localisation of Glandular and Squamous Cell Markers in Non-small Cell Lung Cancer.
Koyi H; Brandén E; Kasim I; Wilander E
Anticancer Res; 2018 Jun; 38(6):3341-3346. PubMed ID: 29848682
[TBL] [Abstract][Full Text] [Related]
12. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of patients with small cell carcinoma of the lung: a histochemical and immunohistochemical study.
Ishida T; Nishino T; Oka T; Yasumoto K; Sugimachi K; Hara N; Ohta M
J Surg Oncol; 1989 Mar; 40(3):188-93. PubMed ID: 2465455
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of histologic subtyping in small cell lung cancer.
Bepler G; Neumann K; Holle R; Havemann K; Kalbfleisch H
Cancer; 1989 Jul; 64(1):74-9. PubMed ID: 2543496
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
16. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical markers of prolonged survival in small cell carcinoma of the lung. An immunohistochemical study.
Sloman A; D'Amico F; Yousem SA
Arch Pathol Lab Med; 1996 May; 120(5):465-72. PubMed ID: 8639050
[TBL] [Abstract][Full Text] [Related]
18. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC
Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of preoperative tumor marker levels and lymphovascular invasion in pathological stage I adenocarcinoma and squamous cell carcinoma of the lung.
Kinoshita T; Ohtsuka T; Yotsukura M; Asakura K; Goto T; Kamiyama I; Otake S; Tajima A; Emoto K; Hayashi Y; Kohno M
J Thorac Oncol; 2015 Apr; 10(4):619-28. PubMed ID: 25634009
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].
De Angelis G; De Marinis F; Bigioni D; Migliorino MR; Alma MG; Pigorini F
J Nucl Med Allied Sci; 1990; 34(4 Suppl):135-40. PubMed ID: 1965445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
